Back to search

References (19)

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States

1997 • 1,628 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

Innate immune sensing and its roots: the story of endotoxin

2003 • 1,316 citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

2007 • 1,287 citations

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

2002 • 772 citations

Vaccinations and the Risk of Relapse in Multiple Sclerosis

2001 • 482 citations

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

2007 • 456 citations

Hepatitis B Vaccination and the Risk of Multiple Sclerosis

2001 • 430 citations

Vaccination and autoimmune disease: what is the evidence?

2003 • 351 citations

Consequence or coincidence?

2005 • 252 citations

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines

2005 • 215 citations

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

2005 • 207 citations

New hepatitis B vaccine formulated with an improved adjuvant system

2007 • 181 citations

Human Papilloma Virus Immunization in Adolescent and Young Adults

2007 • 107 citations

The societal value of universal childhood vaccination

2003 • 40 citations

Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer

2007 • 33 citations

Hepatitis B vaccination and multiple sclerosis: the jury is still out

2005 • 24 citations

Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer

2007 • 12 citations

Cited By (0)

No citing papers found in database

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety… (2008) – Vaccine | Metascience Observatory Explorer